Cavassini M - Search Results

1

Changes in mental and sexual health among MSM using HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: longitudinal analysis of the SwissPrEPared cohort study.

Winter BL, Hovaguimian F, Kouyos RD, Schmidt AJ, Bernasconi E, Braun DL, Calmy A, Notter J, Stoeckle M, Surial B, Christinet V, Cavassini M, Depmeier C, Läuchli S, Boffi El Amari E, Reinacher M, Rasi M, Bruggmann P, Haerry D, Bize R, Low N, Lehner A, Quednow BB, Fehr JS, Hampel B. Winter BL, et al. Among authors: cavassini m. Swiss Med Wkly. 2022 Jun 27;152:w30192. doi: 10.4414/smw.2022.w30192. eCollection 2022 Jun 20. Swiss Med Wkly. 2022. PMID: 35758418 Free article.

2

Long-term safety of discontinuation of secondary prophylaxis against Pneumocystis pneumonia: prospective multicentre study.

Zellweger C, Opravil M, Bernasconi E, Cavassini M, Bucher HC, Schiffer V, Wagels T, Flepp M, Rickenbach M, Furrer H; Swiss HIV Cohort Study. Zellweger C, et al. Among authors: cavassini m. AIDS. 2004 Oct 21;18(15):2047-53. doi: 10.1097/00002030-200410210-00009. AIDS. 2004. PMID: 15577626

3

Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.

Kaufmann GR, Furrer H, Ledergerber B, Perrin L, Opravil M, Vernazza P, Cavassini M, Bernasconi E, Rickenbach M, Hirschel B, Battegay M; Swiss HIV Cohort Study. Kaufmann GR, et al. Among authors: cavassini m. Clin Infect Dis. 2005 Aug 1;41(3):361-72. doi: 10.1086/431484. Epub 2005 Jun 24. Clin Infect Dis. 2005. PMID: 16007534 Free article.

4

Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study.

Glass TR, De Geest S, Weber R, Vernazza PL, Rickenbach M, Furrer H, Bernasconi E, Cavassini M, Hirschel B, Battegay M, Bucher HC. Glass TR, et al. Among authors: cavassini m. J Acquir Immune Defic Syndr. 2006 Mar;41(3):385-92. doi: 10.1097/01.qai.0000186371.95301.52. J Acquir Immune Defic Syndr. 2006. PMID: 16540942

5

Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission.

Elzi L, Schlegel M, Weber R, Hirschel B, Cavassini M, Schmid P, Bernasconi E, Rickenbach M, Furrer H; Swiss HIV Cohort Study. Elzi L, et al. Among authors: cavassini m. Clin Infect Dis. 2007 Jan 1;44(1):94-102. doi: 10.1086/510080. Epub 2006 Nov 28. Clin Infect Dis. 2007. PMID: 17143823 Free article.

6

Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy.

Wunder DM, Bersinger NA, Fux CA, Mueller NJ, Hirschel B, Cavassini M, Elzi L, Schmid P, Bernasconi E, Mueller B, Furrer H; Swiss HIV Cohort Study. Wunder DM, et al. Among authors: cavassini m. Antivir Ther. 2007;12(2):261-5. Antivir Ther. 2007. PMID: 17503668

7

Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study.

Glass TR, Weber R, Vernazza PL, Rickenbach M, Furrer H, Bernasconi E, Cavassini M, Hirschel B, Battegay M, Bucher HC; Swiss HIV Cohort Study. Glass TR, et al. Among authors: cavassini m. HIV Clin Trials. 2007 Mar-Apr;8(2):77-85. doi: 10.1310/hct0802-77. HIV Clin Trials. 2007. PMID: 17507323

8

Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study.

Ledergerber B, Furrer H, Rickenbach M, Lehmann R, Elzi L, Hirschel B, Cavassini M, Bernasconi E, Schmid P, Egger M, Weber R; Swiss HIV Cohort Study. Ledergerber B, et al. Among authors: cavassini m. Clin Infect Dis. 2007 Jul 1;45(1):111-9. doi: 10.1086/518619. Epub 2007 May 21. Clin Infect Dis. 2007. PMID: 17554711 Free article.

9

CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy.

Wolbers M, Battegay M, Hirschel B, Furrer H, Cavassini M, Hasse B, Vernazza PL, Bernasconi E, Kaufmann G, Bucher HC; Swiss HIV Cohort Study. Wolbers M, et al. Among authors: cavassini m. Antivir Ther. 2007;12(6):889-97. Antivir Ther. 2007. PMID: 17926643

10

Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study.

Wolbers M, Opravil M, von Wyl V, Hirschel B, Furrer H, Cavassini M, Vernazza P, Bernasconi E, Battegay M, Yerly S, Günthard H, Bucher HC; Swiss HIV Cohort Study. Wolbers M, et al. Among authors: cavassini m. AIDS. 2007 Oct 18;21(16):2201-7. doi: 10.1097/QAD.0b013e3282efacb1. AIDS. 2007. PMID: 18090047

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

709 results

Search Page

Filters